We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Merck’s Emend for Pediatric Use
The FDA has approved Merck’s anti-nausea and vomiting drug Emend for children undergoing chemotherapy, making the drug the first and only NK1 receptor antagonist for this indication.